Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome study

Author:

Lim Jihye1,Lee Jung‐Bok2,An Jihyun3ORCID,Song Gi‐Won45,Kim Kang Mo15,Lee Han Chu15ORCID,Shim Ju Hyun15ORCID

Affiliation:

1. Gastroenterology, Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

2. Clinical Epidemiology and Biostatistics University of Ulsan College of Medicine, Asan Medical Center Seoul Republic of Korea

3. Gastroenterology, Hanyang University College of Medicine Guri Republic of Korea

4. Hepatobiliary Surgery and Liver Transplantation, Surgery, Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

5. Asan Liver Center, Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

Funder

Asan Institute for Life Sciences, Asan Medical Center

National Research Foundation of Korea

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Reference53 articles.

1. KASL clinical practice guidelines for management of chronic hepatitis B

2. World Health Organization.Hepatitis B. Available at:https://www.who.int/news‐room/fact‐sheets/detail/hepatitis‐b. Accessed November 13 2020.

3. GlaxoSmithKline.EPIVIR (lamivudine) [package insert]. Available at:https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020564s37_020596s036lbl.pdf. Accessed November 13 2020.

4. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

5. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3